Palifermin - Amgen
At a glance
- Drug Originator Amgen
- Drug Licenced by BL-&-H
- Drug Class Chemoprotectants; Fibroblast growth factors
- Mechanism of Action Fibroblast growth factor replacements
- USA Patent Applicants BIOVITRUM AB
- USA Patents 60
- BLAs 1
- International Patents 731
Disclaimer